134 related articles for article (PubMed ID: 31177990)
1. An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN).
Tauziède-Espariat A; Debily MA; Castel D; Grill J; Puget S; Sabel M; Blomgren K; Gareton A; Dangouloff-Ros V; Lechapt E; Boddaert N; Varlet P
Acta Neuropathol Commun; 2019 Jun; 7(1):87. PubMed ID: 31177990
[No Abstract] [Full Text] [Related]
2. The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts.
Tauziède-Espariat A; Debily MA; Castel D; Grill J; Puget S; Roux A; Saffroy R; Pagès M; Gareton A; Chrétien F; Lechapt E; Dangouloff-Ros V; Boddaert N; Varlet P
Acta Neuropathol Commun; 2020 Jul; 8(1):104. PubMed ID: 32646492
[No Abstract] [Full Text] [Related]
3. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.
Barrow J; Adamowicz-Brice M; Cartmill M; MacArthur D; Lowe J; Robson K; Brundler MA; Walker DA; Coyle B; Grundy R
Neuro Oncol; 2011 Feb; 13(2):212-22. PubMed ID: 21138945
[TBL] [Abstract][Full Text] [Related]
4. Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex.
Chan E; Bollen AW; Sirohi D; Van Ziffle J; Grenert JP; Kline CN; Tihan T; Perry A; Gupta N; Solomon DA
Acta Neuropathol; 2017 Oct; 134(4):671-673. PubMed ID: 28776091
[No Abstract] [Full Text] [Related]
5. Brainstem angiocentric gliomas with MYB-QKI rearrangements.
D'Aronco L; Rouleau C; Gayden T; Crevier L; Décarie JC; Perreault S; Jabado N; Bandopadhayay P; Ligon KL; Ellezam B
Acta Neuropathol; 2017 Oct; 134(4):667-669. PubMed ID: 28803398
[No Abstract] [Full Text] [Related]
6. NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas.
Dahl NA; Donson AM; Sanford B; Wang D; Walker FM; Gilani A; Foreman NK; Tinkle CL; Baker SJ; Hoffman LM; Venkataraman S; Vibhakar R
J Neuropathol Exp Neurol; 2021 Mar; 80(4):345-353. PubMed ID: 33749791
[TBL] [Abstract][Full Text] [Related]
7. Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome.
Schoof M; Kordes U; Volk AE; Al-Kershi S; Kresbach C; Schüller U
Acta Neuropathol; 2021 Sep; 142(3):591-593. PubMed ID: 34264394
[No Abstract] [Full Text] [Related]
8. An epigenetic therapy for diffuse intrinsic pontine gliomas.
Ramaswamy V; Remke M; Taylor MD
Nat Med; 2014 Dec; 20(12):1378-9. PubMed ID: 25473916
[TBL] [Abstract][Full Text] [Related]
9. Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition.
Taylor IC; Hütt-Cabezas M; Brandt WD; Kambhampati M; Nazarian J; Chang HT; Warren KE; Eberhart CG; Raabe EH
J Neuropathol Exp Neurol; 2015 Aug; 74(8):778-90. PubMed ID: 26115193
[TBL] [Abstract][Full Text] [Related]
10. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.
Mackay A; Burford A; Carvalho D; Izquierdo E; Fazal-Salom J; Taylor KR; Bjerke L; Clarke M; Vinci M; Nandhabalan M; Temelso S; Popov S; Molinari V; Raman P; Waanders AJ; Han HJ; Gupta S; Marshall L; Zacharoulis S; Vaidya S; Mandeville HC; Bridges LR; Martin AJ; Al-Sarraj S; Chandler C; Ng HK; Li X; Mu K; Trabelsi S; Brahim DH; Kisljakov AN; Konovalov DM; Moore AS; Carcaboso AM; Sunol M; de Torres C; Cruz O; Mora J; Shats LI; Stavale JN; Bidinotto LT; Reis RM; Entz-Werle N; Farrell M; Cryan J; Crimmins D; Caird J; Pears J; Monje M; Debily MA; Castel D; Grill J; Hawkins C; Nikbakht H; Jabado N; Baker SJ; Pfister SM; Jones DTW; Fouladi M; von Bueren AO; Baudis M; Resnick A; Jones C
Cancer Cell; 2017 Oct; 32(4):520-537.e5. PubMed ID: 28966033
[TBL] [Abstract][Full Text] [Related]
11. Molecular landscape of pediatric diffuse intrinsic pontine gliomas: about 22 cases.
El Ayoubi R; Boisselier B; Rousseau A
J Neurooncol; 2017 Sep; 134(2):465-467. PubMed ID: 28589424
[No Abstract] [Full Text] [Related]
12. Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.
Schoof M; Godbole S; Albert TK; Dottermusch M; Walter C; Ballast A; Qin N; Olivera MB; Göbel C; Neyazi S; Holdhof D; Kresbach C; Peter LS; Epplen GD; Thaden V; Spohn M; Blattner-Johnson M; Modemann F; Mynarek M; Rutkowski S; Sill M; Varghese J; Afflerbach AK; Eckhardt A; Münter D; Verma A; Struve N; Jones DTW; Remke M; Neumann JE; Kerl K; Schüller U
Nat Commun; 2023 Nov; 14(1):7717. PubMed ID: 38001143
[TBL] [Abstract][Full Text] [Related]
13. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
[TBL] [Abstract][Full Text] [Related]
14. A new era for children with diffuse intrinsic pontine glioma: hope for cure?
Jansen MH; Kaspers GJ
Expert Rev Anticancer Ther; 2012 Sep; 12(9):1109-12. PubMed ID: 23098109
[No Abstract] [Full Text] [Related]
15. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
Hashizume R; Andor N; Ihara Y; Lerner R; Gan H; Chen X; Fang D; Huang X; Tom MW; Ngo V; Solomon D; Mueller S; Paris PL; Zhang Z; Petritsch C; Gupta N; Waldman TA; James CD
Nat Med; 2014 Dec; 20(12):1394-6. PubMed ID: 25401693
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.
Panditharatna E; Yaeger K; Kilburn LB; Packer RJ; Nazarian J
Cancer Genet; 2015; 208(7-8):367-73. PubMed ID: 26206682
[TBL] [Abstract][Full Text] [Related]
17. Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma.
Koschmann C; Zamler D; MacKay A; Robinson D; Wu YM; Doherty R; Marini B; Tran D; Garton H; Muraszko K; Robertson P; Leonard M; Zhao L; Bixby D; Peterson L; Camelo-Piragua S; Jones C; Mody R; Lowenstein PR; Castro MG
Oncotarget; 2016 Oct; 7(40):65696-65706. PubMed ID: 27582545
[TBL] [Abstract][Full Text] [Related]
18. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
Hoffman LM; DeWire M; Ryall S; Buczkowicz P; Leach J; Miles L; Ramani A; Brudno M; Kumar SS; Drissi R; Dexheimer P; Salloum R; Chow L; Hummel T; Stevenson C; Lu QR; Jones B; Witte D; Aronow B; Hawkins CE; Fouladi M
Acta Neuropathol Commun; 2016 Jan; 4():1. PubMed ID: 26727948
[TBL] [Abstract][Full Text] [Related]
19. Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma.
Pratt D; Quezado M; Abdullaev Z; Hawes D; Yang F; Garton HJL; Judkins AR; Mody R; Chinnaiyan A; Aldape K; Koschmann C; Venneti S
Acta Neuropathol Commun; 2020 Mar; 8(1):37. PubMed ID: 32197665
[No Abstract] [Full Text] [Related]
20. Biopsy for diffuse intrinsic pontine glioma: a reappraisal.
Kieran MW; Goumnerova LC; Prados M; Gupta N
J Neurosurg Pediatr; 2016 Sep; 18(3):390-1. PubMed ID: 27153377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
